Anti-SMAD1 monoclonal antibody
Pre-made anti-SMAD1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to SMAD1/SMAD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2743-Ab-1/ GM-Tg-hg-IP2743-Ab-2 | Anti-Human SMAD1 monoclonal antibody | Human |
GM-Tg-rg-IP2743-Ab-1/ GM-Tg-rg-IP2743-Ab-2 | Anti-Rat SMAD1 monoclonal antibody | Rat |
GM-Tg-mg-IP2743-Ab-1/ GM-Tg-mg-IP2743-Ab-2 | Anti-Mouse SMAD1 monoclonal antibody | Mouse |
GM-Tg-cynog-IP2743-Ab-1/ GM-Tg-cynog-IP2743-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SMAD1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2743-Ab-1/ GM-Tg-felg-IP2743-Ab-2 | Anti-Feline SMAD1 monoclonal antibody | Feline |
GM-Tg-cang-IP2743-Ab-1/ GM-Tg-cang-IP2743-Ab-2 | Anti-Canine SMAD1 monoclonal antibody | Canine |
GM-Tg-bovg-IP2743-Ab-1/ GM-Tg-bovg-IP2743-Ab-2 | Anti-Bovine SMAD1 monoclonal antibody | Bovine |
GM-Tg-equg-IP2743-Ab-1/ GM-Tg-equg-IP2743-Ab-2 | Anti-Equine SMAD1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2743-Ab-1/ GM-Tg-hg-IP2743-Ab-2; GM-Tg-rg-IP2743-Ab-1/ GM-Tg-rg-IP2743-Ab-2; GM-Tg-mg-IP2743-Ab-1/ GM-Tg-mg-IP2743-Ab-2; GM-Tg-cynog-IP2743-Ab-1/ GM-Tg-cynog-IP2743-Ab-2; GM-Tg-felg-IP2743-Ab-1/ GM-Tg-felg-IP2743-Ab-2; GM-Tg-cang-IP2743-Ab-1/ GM-Tg-cang-IP2743-Ab-2; GM-Tg-bovg-IP2743-Ab-1/ GM-Tg-bovg-IP2743-Ab-2; GM-Tg-equg-IP2743-Ab-1/ GM-Tg-equg-IP2743-Ab-2 |
Products Name | Anti-SMAD1 monoclonal antibody |
Format | mab |
Target Name | SMAD1 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-SMAD1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2743-Ag-1 | Recombinant multi-species SMAD1/ BSP-1/ BSP1 protein |
Cytokine | GM-Tg-g-IP2743-Ag-1 | SMAD family member 1 (SMAD1) protein |
ORF Viral Vector | vGMAP000218 | Human SMAD1 Adenovirus particle |
ORF Viral Vector | pGMLP000523 | human SMAD1 Lentivirus plasmid |
ORF Viral Vector | pGMAP000218 | Human SMAD1 Adenovirus plasmid |
ORF Viral Vector | vGMLP000523 | human SMAD1 Lentivirus particle |
Target information
Target ID | GM-IP2743 |
Target Name | SMAD1 |
Gene ID | 4086,17125,25671,574340,475456,101085713,540488,100033850 |
Gene Symbol and Synonyms | BSP-1,BSP1,dwf-A,JV4-1,JV41,Mad1,MADH1,MADR1,Mlp1,mMad1,MusMLP,SMAD1 |
Uniprot Accession | Q15797,P97588,Q1JQA2 |
Uniprot Entry Name | SMAD1_HUMAN,SMAD1_RAT,SMAD1_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | Cytokine Target |
Disease | Cancer |
Gene Ensembl | ENSG00000170365 |
Target Classification | Tumor-associated antigen (TAA) |
The target: SMAD1, gene name: SMAD1, also named as BSP-1, BSP1, JV4-1, JV41, MADH1, MADR1. The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signals of the bone morphogenetic proteins (BMPs), which are involved in a range of biological activities including cell growth, apoptosis, morphogenesis, development and immune responses. In response to BMP ligands, this protein can be phosphorylated and activated by the BMP receptor kinase. The phosphorylated form of this protein forms a complex with SMAD4, which is important for its function in the transcription regulation. This protein is a target for SMAD-specific E3 ubiquitin ligases, such as SMURF1 and SMURF2, and undergoes ubiquitination and proteasome-mediated degradation. Alternatively spliced transcript variants encoding the same protein have been observed. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.